Siga Technologies (SIGA) Cash from Investing Activities (2010 - 2025)
Siga Technologies (SIGA) posted Cash from Investing Activities of -$289576.0 for Q3 2025, down 28957500.0% on a QoQ basis from -$1.0 in Q2 2025, and down 1191.19% year-over-year from $26537.5 in Q3 2024.
Siga Technologies (SIGA) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Siga Technologies' Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$289576.0 for Q3 2025.
- Quarterly Cash from Investing Activities fell 1191.19% year-over-year to -$289576.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$332308.0 (down 1250.19% YoY) and the FY2024 annual result came in at -$42450.0, down 95.75% from the prior year.
- Cash from Investing Activities was -$289576.0 for Q3 2025 at Siga Technologies, down from -$1.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1.0 in Q2 2025 and bottomed at -$289576.0 in Q3 2025.
- A 4-year average of -$42922.6 and a median of -$19762.0 in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 99.95% in 2025, while the deepest fall reached 1191.19% in 2025.
- Siga Technologies' Cash from Investing Activities stood at -$26196.0 in 2021, then climbed by 17.22% to -$21686.0 in 2023, then increased by 17.74% to -$17838.0 in 2024, then plunged by 1523.37% to -$289576.0 in 2025.
- Business Quant data shows SIGA's Cash from Investing Activities at -$289576.0 in Q3 2025, -$1.0 in Q2 2025, and -$24893.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Siga Technologies | 223.05 Mn | 68.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -289,576.00 |
| Sep 30, 2025 | -289,576.00 |
| Jun 30, 2025 | -1.00 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -24,893.00 |
| Mar 31, 2025 | -24,893.00 |
| Dec 31, 2024 | -17,838.00 |
| Dec 31, 2024 | -17,838.00 |
| Sep 30, 2024 | -22,427.00 |
| Sep 30, 2024 | -22,427.00 |
| Jun 30, 2024 | -2,185.00 |
| Jun 30, 2024 | -2,185.00 |
| Jun 30, 2023 | -21,686.00 |
| Jun 30, 2023 | -21,686.00 |
| Dec 31, 2021 | -26,196.00 |
| Dec 31, 2021 | -26,196.00 |
| Jun 30, 2021 | -10,700.00 |
| Jun 30, 2021 | -10,700.00 |
| Mar 31, 2021 | -13,724.00 |
| Mar 31, 2021 | -13,724.00 |